首页> 外文期刊>Canadian journal of gastroenterology & hepatology. >Renal Dysfunction is a Risk Factor of Death after Gastric Endoscopic Submucosal Dissection in Elderly Patients Aged ≥80?Years
【24h】

Renal Dysfunction is a Risk Factor of Death after Gastric Endoscopic Submucosal Dissection in Elderly Patients Aged ≥80?Years

机译:肾功能紊乱是患者患者胃肠内镜粘膜缺陷症患者≥80岁的患者患者死亡危险因素

获取原文
       

摘要

Introduction. Endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) is well accepted. However, its adaptation for elderly patients is unclear. This study aimed to investigate the prognosis and long-term outcomes of ESD for EGC in elderly patients aged ≥80?years by comparing their findings to the findings of patients aged 80?years. Materials and Methods. The study included 533 patients (632 lesions). The patients were divided into an elderly group (age, ≥80?years; 108 patients; 128 lesions; mean age, 83.4?±?2.7?years) and a nonelderly group (age, 80?years; 425 patients; 504 lesions; mean age, 69.6?±?7.9?years). We compared patient and lesion characteristics, overall survival (OS), and disease-specific survival (DSS) between the 2 groups retrospectively. Multivariate analysis was performed to clarify the risk factors of death after ESD. Results. The rate of curative resection and adverse events was not significantly different between the groups. The mean survival time periods with regard to OS/DSS in the elderly and nonelderly groups were 75.8?±?5.9 and 122.8?±?2.6?months (P0.05)/120.0?±?3.0 and 136.4?±?0.6?months (not significant), respectively. In the elderly group, eGFR 30?ml/min/1.73?m2 was an independent risk factor of death (hazard ratio?=?5.32; 95% confidence interval?=?1.39–20.5; P=0.015). Conclusion. ESD for EGC can be performed safely and can achieve high curability with good prognosis in elderly patients aged ≥80?years. After ESD, close attention should be paid to elderly patients with severe chronic kidney disease.
机译:介绍。对早期胃癌(EGC)的内窥镜粘膜粘膜解剖(ESD)受到很好地接受。然而,它对老年患者的适应尚不清楚。本研究旨在探讨≥80岁≥80岁的老年患者EGC的预后和长期成果,通过将他们的研究结果与年龄<80岁的患者的研究结果进行比较。材料和方法。该研究包括533名患者(632名病变)。将患者分为一名老年人(年龄,≥80岁; 108名患者; 128个病变;平均年龄,83.4?±2.7?年)和一个非先辈组(年龄,<80?岁; 425名病变;平均年龄,69.6?±7.9?年)。我们将患者和病变特征进行比较回顾两组之间的患者和病变特征,整体存活(OS)和疾病特异性的存活率(DSS)。进行多元分析以澄清ESD后死亡的危险因素。结果。在组之间治疗切除率和不良事件的速率没有显着差异。关于老年人和非先名组织和非均方组的MEN / DSS的平均存活时间段为75.8?±5.9和122.8?±2.6?月份(P <0.05)/120.0?±?3.0和136.4?±0.6?月(不重要)分别。在老年人群中,EGFR <30?ml / min / 1.73?M2是死亡的独立风险因素(危险比?=?5.32; 95%置信区间?=?1.39-20.5; P = 0.015)。结论。 ESD用于EGC可以安全地进行,可以在≥80岁≥80岁的老年患者中具有良好预后的高可验性。 ESD后,应对老年慢性肾病患者进行密切关注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号